These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7576126)

  • 21. Transcription of HLA-G transgenes commences shortly after implantation during embryonic development in mice.
    Horuzsko A; Tomlinson PD; Strachan T; Mellor AL
    Immunology; 1994 Oct; 83(2):324-8. PubMed ID: 7530689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen processing and presentation by the class I major histocompatibility complex.
    York IA; Rock KL
    Annu Rev Immunol; 1996; 14():369-96. PubMed ID: 8717519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The significance of HLA-G for miscarriages].
    Grzywacz M; Ronin-Walknowska E
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):105-14. PubMed ID: 15537250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regulation of the expression of HLA class I genes in human trophoblasts].
    Le Bouteiller P
    Pathol Biol (Paris); 1995 Sep; 43(7):628-35. PubMed ID: 8570269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic lymphocyte recognition of HLA-E: utilizing a nonclassical window to peer into classical MHC.
    Leibson PJ
    Immunity; 1998 Sep; 9(3):289-94. PubMed ID: 9768748
    [No Abstract]   [Full Text] [Related]  

  • 26. MHC class I antigen processing pathways.
    Maffei A; Papadopoulos K; Harris PE
    Hum Immunol; 1997 May; 54(2):91-103. PubMed ID: 9297528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonclassical HLA-G molecules are classical peptide presenters.
    Diehl M; Münz C; Keilholz W; Stevanović S; Holmes N; Loke YW; Rammensee HG
    Curr Biol; 1996 Mar; 6(3):305-14. PubMed ID: 8805247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viewpoint on the functionality of the human leukocyte antigen-G null allele at the fetal-maternal interface.
    Moreau P; Dausset J; Carosella ED; Rouas-Freiss N
    Biol Reprod; 2002 Nov; 67(5):1375-8. PubMed ID: 12390865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic heterogeneity of human cytotrophoblast and evidence for the transient expression of MHC class I antigens distinct from HLA-G.
    Shorter SC; Starkey PM; Ferry BL; Clover LM; Sargent IL; Redman CW
    Placenta; 1993; 14(5):571-82. PubMed ID: 7507243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
    Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
    J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen presentation by non-classical class I molecules.
    Stroynowski I; Lindahl KF
    Curr Opin Immunol; 1994 Feb; 6(1):38-44. PubMed ID: 8172679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.
    Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K
    J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.
    Clements CS; Kjer-Nielsen L; Kostenko L; Hoare HL; Dunstone MA; Moses E; Freed K; Brooks AG; Rossjohn J; McCluskey J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3360-5. PubMed ID: 15718280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-G revisited.
    Carosella ED; Dausset J; Kirszenbaum M
    Immunol Today; 1996 Sep; 17(9):407-9. PubMed ID: 8854556
    [No Abstract]   [Full Text] [Related]  

  • 35. Is restricted antigen presentation the explanation for fetal allograft survival?
    Wood GW
    Immunol Today; 1994 Jan; 15(1):15-8. PubMed ID: 8136007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
    Rajagopalan S; Long EO
    J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune modulation of HLA-G dimer in maternal-fetal interface.
    Kuroki K; Maenaka K
    Eur J Immunol; 2007 Jul; 37(7):1727-9. PubMed ID: 17587197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do nonhuman primates comprise appropriate experimental models for studying the function of human leukocyte antigen-G?
    Langat DK; Hunt JS
    Biol Reprod; 2002 Nov; 67(5):1367-74. PubMed ID: 12390864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-G: a shield against inflammatory aggression.
    Carosella ED; Moreau P; Aractingi S; Rouas-Freiss N
    Trends Immunol; 2001 Oct; 22(10):553-5. PubMed ID: 11574278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen presentation by major histocompatibility complex class I-B molecules.
    Shawar SM; Vyas JM; Rodgers JR; Rich RR
    Annu Rev Immunol; 1994; 12():839-80. PubMed ID: 8011299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.